APTFM
BIIB icon

AGUR Provident & Training Funds Management’s Biogen BIIB Stock Holding History

AGUR Provident & Training Funds Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,324
Closed -$1.35M – 24
2016
Q3 		$1.35M Hold
4,324
– – 1.01% 19
2016
Q2 		$1.05M Buy
+4,324
New +$1.14M 0.7% 23

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AGUR Provident & Training Funds Management's BIIB Position: Q4 2016 in Review

AGUR Provident & Training Funds Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 4,324 shares — an estimated $1.35M sold.

AGUR Provident & Training Funds Management first reported a position in BIIB in Q2 2016 and held it in 2 quarters. The position peaked at $1.35M in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • AGUR Provident & Training Funds Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • AGUR Provident & Training Funds Management sold 4,324 Biogen shares in Q4 2016, an estimated $1.35M.
  • AGUR Provident & Training Funds Management first reported a position in Biogen in Q2 2016 and held it in 2 quarters.
  • AGUR Provident & Training Funds Management's Biogen position peaked at $1.35M in Q3 2016.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on AGUR Provident & Training Funds Management's 13F filing for Q4 2016, filed 13 Feb 2017.